NCT07534553

Brief Summary

Robot-assisted laparoscopic radical prostatectomy (RALP) requires steep Trendelenburg positioning and pneumoperitoneum, which adversely affect respiratory mechanics and may lead to impaired postoperative oxygenation. Mechanical power (MP) has recently emerged as a comprehensive parameter reflecting the total energy delivered from the ventilator to the respiratory system and may be associated with ventilator-induced lung injury. This prospective randomized controlled trial aims to evaluate whether a mechanical power-targeted ventilation strategy improves postoperative oxygenation compared to standard ventilation in patients undergoing RALP. The primary outcome is the oxygenation index (OSI) at the postoperative second hour. Secondary outcomes include PaO₂/FiO₂ ratio, postoperative pulmonary complications, and length of hospital stay.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Apr 2026Jul 2026

First Submitted

Initial submission to the registry

April 10, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

April 15, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 16, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2026

Last Updated

April 16, 2026

Status Verified

April 1, 2026

Enrollment Period

2 months

First QC Date

April 10, 2026

Last Update Submit

April 10, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Oxygenation Index (OSI)

    OSI calculation: OSI = FiO₂ × MAP × 100 / SpO₂

    postoperative 2nd hour

Secondary Outcomes (4)

  • PaO₂/FiO₂ ratio

    Intraoperative period and postoperative 2 hours

  • Postoperative pulmonary complications (PPC)

    Within 7 postoperative days

  • Intraoperative respiratory mechanics

    During surgery (from intubation to extubation)

  • Mechanical power changes

    During surgery (at predefined intraoperative time points)

Study Arms (2)

Mechanical Power-Targeted Ventilation

EXPERIMENTAL

Patients receive ventilation adjusted to achieve the lowest possible mechanical power (≤14 J/min) by titrating PEEP and respiratory rate.

Procedure: Mechanical Power-Targeted VentilationProcedure: Standard Ventilation

Standard Ventilation

ACTIVE COMPARATOR

Patients receive conventional ventilation with fixed PEEP (5 cmH₂O) and routine ventilator settings.

Procedure: Mechanical Power-Targeted VentilationProcedure: Standard Ventilation

Interventions

Ventilation adjusted to achieve the lowest possible mechanical power (≤14 J/min) using titration of PEEP and respiratory rate.

Mechanical Power-Targeted VentilationStandard Ventilation

Conventional ventilation strategy with fixed PEEP (5 cmH₂O) and routine settings.

Mechanical Power-Targeted VentilationStandard Ventilation

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years
  • Elective RALP
  • ASA I-III

You may not qualify if:

  • Severe pulmonary disease (advanced COPD, ILD)
  • Preoperative oxygen requirement
  • Emergency surgery
  • BMI \> 40 kg/m²

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Bilkent City Hospital

Ankara, Turkey (Türkiye)

Location

Central Study Contacts

Betül Güven Aytaç, Assos Prof

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Single (Outcome Assessor
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assos. Prof

Study Record Dates

First Submitted

April 10, 2026

First Posted

April 16, 2026

Study Start

April 15, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

July 30, 2026

Last Updated

April 16, 2026

Record last verified: 2026-04

Locations